Latest biopharmaceutical Stories
-Extended Follow-Up Shows 4/14 Patients Treated with a Single SC Dose of 2 mg/kg of RG-101 are Target Not Detected at Day 85 - LA JOLLA, Calif., Feb.
DALLAS and NEW YORK, Feb. 6, 2015 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
BCC Research (http://www.bccresearch.com) reveals in its new report on biologic therapeutic drugs; the biologics or biopharmaceutical therapeutic
EWING, N.J., Feb. 2, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
EDISON, N.J., Feb. 2, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
COPENHAGEN, Denmark and SEATTLE, Jan. 30, 2015 /PRNewswire/ -- Serendex Pharmaceuticals A/S (XOSL: SENDEX) and CMC Biologics, Inc. have today signed an exclusive agreement on Factor VIIa.
- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,
MILFORD, Mass., Jan.
ROCKVILLE, Md., Jan. 28, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc.
TEL-AVIV, Israel, Jan. 28, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
- A political dynamiter.